EV/EBITDA
-2.21
-0.07-3.27%
Tue, 04 Mar 2025 22:37:14 GMT
Summary
- As of March 5, 2025, STOK EV/EBITDA is -2.21, with a fall of -0.07 (-3.27%) during the most recent trading day.
- Over the past year, STOK EV/EBITDA has dropped by -0.96 (-76.80%).
- STOK EV/EBITDA is now -731.43% below its all-time high of 0.35.
Performance
STOK EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
STOK EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -3.3% | +3.2% | +2.0% |
| 1 m1 month | +51.1% | -51.2% | -39.8% |
| 3 m3 months | +52.1% | -52.2% | -40.8% |
| 6 m6 months | +60.3% | -59.4% | -51.1% |
| ytdytd | +41.7% | -41.9% | -31.3% |
| 1 y1 year | -76.8% | +80.3% | +5.4% |
| 5 y5 years | +88.6% | -62.9% | -72.5% |
STOK EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.3% | -4.56 | +51.5% | |
| 3 m | 3-month | -2.14 | -3.3% | -5.05 | +56.2% |
| 6 m | 6-month | -2.14 | -3.3% | -5.77 | +61.7% |
| 1 y | 1-year | -0.83 | -166.3% | -6.30 | +64.9% |
| 3 y | 3-year | 0.35 | -731.4% | -9.77 | +77.4% |
| 5 y | 5-year | 0.35 | -731.4% | -43.47 | +94.9% |
| alltime | all time | 0.35 | -731.4% | -48.38 | +95.4% |
Stoke Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.21(-41.7%) |
| 2024 | -3.79(+689.6%) |
| 2023 | -0.48(-80.5%) |
| Date | Value |
|---|---|
| 2022 | -2.46(-71.8%) |
| 2021 | -8.72(-77.0%) |
| 2020 | -37.94(+88.8%) |
| 2019 | -20.10 |
FAQ
- What is Stoke Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Stoke Therapeutics?
- What is STOK EV/EBITDA year-to-date change?
- What is Stoke Therapeutics EV/EBITDA year-on-year change?
What is Stoke Therapeutics EV/EBITDA?
The current EV/EBITDA of STOK is -2.21
What is the all time high EV/EBITDA for Stoke Therapeutics?
Stoke Therapeutics all-time high EV/EBITDA is 0.35
What is STOK EV/EBITDA year-to-date change?
Stoke Therapeutics EV/EBITDA has changed by +1.58 (+41.69%) since the beginning of the year
What is Stoke Therapeutics EV/EBITDA year-on-year change?
Over the past year, STOK EV/EBITDA has changed by -0.96 (-76.80%)